Biomea Fusion (BMEA, Financial) received a notable endorsement from Piper Sandler, with analyst Edward Tenthoff initiating coverage with an "Overweight" rating. This signifies a positive outlook on the stock's future performance.
In addition to the rating, Piper Sandler announced a price target of $7.00 for Biomea Fusion (BMEA, Financial). This initiation reflects the analyst's confidence in the company's potential to deliver significant returns to investors.
While previous price targets were not disclosed, the new guidance from Piper Sandler serves as a fresh reference point for investors looking at Biomea Fusion (BMEA, Financial). The coverage initiation is part of ongoing analysis by industry experts aiming to provide insights into market opportunities.
Investors should note that the provided price target and rating are in USD, in line with the listing on the NASDAQ exchange. As of June 3, 2025, Biomea Fusion (BMEA, Financial) will be under watch by Piper Sandler for any developments affecting its market standing.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Biomea Fusion Inc (BMEA, Financial) is $20.00 with a high estimate of $54.00 and a low estimate of $3.00. The average target implies an upside of 992.90% from the current price of $1.83. More detailed estimate data can be found on the Biomea Fusion Inc (BMEA) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Biomea Fusion Inc's (BMEA, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
